DR Congo: Repression Persists as Election Deadline
Nears
Ebola death toll in DR Congo at 41, new drug in use
Tuesday August 14 2018
Forty-one people have died in the latest
outbreak of Ebola in DR Congo, health authorities said on Tuesday,
adding that doctors were using a novel drug to treat patients.
Out of 57 recorded cases as of Monday, 41 were fatal, the Congolese Health Ministry and UN's World Health Organization (WHO) said. Fourteen of the deaths had been confirmed by lab tests, the ministry said.
Last Friday, the ministry put the tally at 37 deaths, either confirmed or suspected.
Out of 57 recorded cases as of Monday, 41 were fatal, the Congolese Health Ministry and UN's World Health Organization (WHO) said. Fourteen of the deaths had been confirmed by lab tests, the ministry said.
Last Friday, the ministry put the tally at 37 deaths, either confirmed or suspected.
The
outbreak is the country's 10th since 1976, when the disease was first
identified in the Democratic Republic of Congo (DRC) near the Ebola
River, a tributary of the Congo.
Its epicentre is Mangina in the region of Beni, in the strife-torn eastern province of North Kivu.
For the first time since the outbreak was announced on August 1, one fatality was recorded outside of North Kivu -- in the neighbouring province of Ituri, the ministry's directorate for disease control said.
It added that doctors in Beni had started to use a novel treatment called mAb114 to treat patients with Ebola.
Its epicentre is Mangina in the region of Beni, in the strife-torn eastern province of North Kivu.
For the first time since the outbreak was announced on August 1, one fatality was recorded outside of North Kivu -- in the neighbouring province of Ituri, the ministry's directorate for disease control said.
It added that doctors in Beni had started to use a novel treatment called mAb114 to treat patients with Ebola.
The treatment is "the first therapeutic drug against the virus to be used in an active Ebola epidemic in the DRC," it said.
Developed in the United States, the prototype drug is a so-called single monoclonal antibody -- a protein that binds on to a specific target of the virus and triggers the body's immune system to destroy the invader.
The antibody was isolated from a survivor of an Ebola outbreak in the western DRC city of Kikwit in 1995, it said.
Developed in the United States, the prototype drug is a so-called single monoclonal antibody -- a protein that binds on to a specific target of the virus and triggers the body's immune system to destroy the invader.
The antibody was isolated from a survivor of an Ebola outbreak in the western DRC city of Kikwit in 1995, it said.
In
May, the US National Institute of Allergy and Infectious Diseases
(NIAID) said it was carrying out the first human trials of mAb114 to
test it for safety and tolerance.
Fighting could hamper treatment
Use of the experimental treatment in the field comes on the heels of deployment of an unlicensed vaccine in an earlier outbreak of Ebola in the DRC this year.
The decision to use the vaccine, called rVSV-ZEBOV, came after trials during a pandemic in West Africa showed it to be safe and effective, the WHO says.
Use of the experimental treatment in the field comes on the heels of deployment of an unlicensed vaccine in an earlier outbreak of Ebola in the DRC this year.
The decision to use the vaccine, called rVSV-ZEBOV, came after trials during a pandemic in West Africa showed it to be safe and effective, the WHO says.
Immunisation
with rVSV-ZEBOV was given to front-line health workers to provide them
with additional protection -- a tactic that has been repeated in the
latest outbreak.
Ebola causes serious illness including vomiting, diarrhoea and in some cases internal and external bleeding. It is often fatal if untreated.
Ebola causes serious illness including vomiting, diarrhoea and in some cases internal and external bleeding. It is often fatal if untreated.
The WHO has expressed concern that
the violence in North Kivu -- entailing militias who often fight for
control of resources, including a notorious Ugandan rebel force called
the Allied Democratic Forces (ADF) -- could hamper the fight against the
new outbreak.
WHO Director General Tedros Adhanom Ghebreyesus, visiting the area, on Sunday called for "free and secure access" for health workers, the agency said in a statement.
WHO Director General Tedros Adhanom Ghebreyesus, visiting the area, on Sunday called for "free and secure access" for health workers, the agency said in a statement.
The
outbreak in North Kivu was declared a week after WHO and the Kinshasa
government hailed the end of a flareup in northwestern Equateur province
which killed 33 people.
In the worst Ebola epidemic, the disease struck the West African states of Guinea, Liberia and Sierra Leone in 2013-15, killing more than 11,300 people.
In the worst Ebola epidemic, the disease struck the West African states of Guinea, Liberia and Sierra Leone in 2013-15, killing more than 11,300 people.
